DV
Dividend Vision

PGEN — Precigen, Inc.

Precigen, Inc. (PGEN)

Total return is -74.2% over the past 13 years, 544.4 points behind SPY at 470.2%. Its deepest 1-year drawdown was 40.5%.

PGEN is an equity fund that holds stock in Precigen, Inc., a biotechnology company. The fund does not currently distribute dividends to shareholders and carries no listed expense ratio or assets under management data. This fund appeals primarily to investors seeking exposure to the biotechnology sector rather than those focused on dividend income.

PGEN key facts

Asset type
Stock
Asset class
Equity
Inception date
08/08/2013
Distribution frequency
None
Last close
$6.10
Market cap
$2,184,014,848
Average volume
7955600.0
Beta
1.009
Payout ratio
0.0
Forward P/E
50.0
EPS
$-1.07